The estrogen receptor variant lacking exon 5 has dominant negative activity in the human breast epithelial cell line HMT-3522S1

Cancer Research

Volumn 58, Issue 19, 1998, Pages 4264-4268

  Ohlsson, Helle ^a   Lykkesfeldt, Anne E ^a   Madsen, Mogens W ^a,b   Briand, Per ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b LEO PHARMA A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; EPITHELIUM CELL; EXON; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE;

BETA-GALACTOSIDASE; BREAST; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; EPITHELIAL CELLS; EXONS; FEMALE; HUMANS; RECEPTORS, ESTROGEN; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; SEQUENCE DELETION; TRANSCRIPTION, GENETIC; TRANSFECTION; VARIATION (GENETICS);

EID: 0032188886     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Edwards, D. P., Chamness, G. C., and McGuire, W. L. Estrogen and progesterone receptor proteins in breast cancer. Biochim. Biophys. Acta., 560: 457-486, 1979.
2. Fuqua, S. A. W., Fitzgerald, S. D., Chamness, G. C., Tandon, A. K., McDonnell, P., Nawaz, Z., O'Malley, B. W., and McGuire, W. L. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res., 51: 105-109, 1991.
3. Wang, Y., and Miksicek, R. J. Identification of a dominant negative form of the human estrogen receptor. Mol. Endocrinol., 5: 1707-1715, 1991.
4. Pfeffer, U., Fecarotta, E., Castagnetta, L., and Vidali, G. Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines. Cancer Res., 53: 741-743, 1993.
5. Castles, C. G., Fuqua, S. A. W., Klotz, D. M., and Hill, S. M. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line. Cancer Res., 53: 5934-5939, 1993.
6. Daffada, A. A. I., Johnston, S. R. D., Smith, I. E., Detre, S., King, N., and Dowsett, M. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer. Cancer Res., 55: 288-293, 1995.
7. Miksicek, R. J., Lei, Y., and Wang, Y. Exon skipping gives rise to alternatively spliced forms of the estrogen receptor in breast tumor cells. Breast Cancer Res. Treat., 26: 163-174, 1993.
8. Rea, D., and Parker, M. G. Effects of an exon 5 variant of the estrogen receptor in MCF-7 breast cancer cells. Cancer Res., 56: 1556-1563, 1996.
9. Desai, A. J., Luqmani, Y. A., Walters, J. E., Coope, R. C., Dagg, B., Gomm, J. J., Pace, P. E., Rees, C. N., Thirunavukkarasu, V., Shousha, S., Groome, N. P., Coombes, R., and Ali, S. Presence of exon 5-deleted oestrogen receptor in human breast cancer: functional analysis and clinical significance. Br. J. Cancer, 75: 1173-1184, 1997.
10. Madsen, M. W., Reiter, B. E., Larsen, S. S., Briand, P., and Lykkesfeldt, A. E. Estrogen receptor messenger RNA splice variants are not involved in antiestrogen resistance in sublines of MCF-7 human breast cancer cells. Cancer Res., 57: 585-589, 1997.
11. Briand, P., Petersen, O. W., and Van Deurs, B. A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium. In Vitro Cell. Dev. Biol., 23: 181-188, 1987.
12. Klein-Hitpass, L., Schorpp, M., Wagner, U., and Ryffel, G. U. An estrogen-responsive element derived from the 5′ flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell, 46: 1053-1061, 1986.
13. Tulchinsky, E., Ford, H. L., Kramerov, D., Reshetnyak, E., Grigorian, M., Zain, S., and Lukanidin, E. Transcriptional analysis of the mts1 gene with specific reference to 5′ flanking sequences. Proc. Natl. Acad. Sci. USA, 89: 9146-9150, 1992.
14. Tora, L., White, J., Brou, C., Tasset, D., Webster, N., Scheer, E., and Chambon, P. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell, 59: 477-487, 1989.
15. Sambrook, J., Fritsch, E. F., and Maniatis, T. In: J. Sambrook, E. F. Fritsch, and T. Maniatis (eds.), Molecular Cloning: A Laboratory Manual, pp. 16.59-16.62 and 16.66-16.67. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
16. Lundholt, B. K., Madsen, M. W., Lykkesfeldt, A. E., Petersen, O. W., and Briand, P. Characterization of a nontumorigenic human breast epithelial cell line stably transfected with the human estrogen receptor (ER). Mol. Cell. Endocrinol., 119: 47-59, 1996.
17. Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J-M., Argos, P., and Chambon, P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature (Lond.), 320: 134-139, 1986.
18. Laborda, J. 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res., 19: 3998, 1991.
19. R-1 compared to the parental MCF-7 cell line. Mol. Cell. Endocrinol., 109: 197-207, 1995.
20. Klotz, D. M., Castles, C. G., Fuqua, S. A. W., Spriggs, L. L., and Hill, S. M. Differential expression of wild-type and variant ER mRNAs by stocks of MCF-7 breast cancer cells may account for differences in estrogen responsiveness. Biochem. Biophys. Res. Commun., 210: 609-615, 1995.
21. Fuqua, S. A. W., and Wolf, D. Molecular aspects of estrogen receptor variants in breast cancer. Breast Cancer Res. Treat., 35: 233-241, 1995.
22. Zhang, Q-X., Borg, Å., and Fuqua, S. A. W. An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer. Cancer Res., 53: 5882-5884, 1993.
23. Koehorst, S. G. A., Cox, J. J., Donker, G. H., Lopes da Silva, S., Burbach, J. P. H., Thijssen, J. H. H., and Blankenstein, M. A. Functional analysis of an alternatively spliced estrogen receptor lacking exon 4 isolated from MCF-7 breast cancer cells and meningioma tissue. Mol. Cell. Endocrinol., 101: 237-245, 1994.
24. Dauvois, S., Danielian, P. S., White, R., and Parker, M. G. Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc. Natl. Acad. Sci. USA, 89: 4037-4041, 1992.
25. Chan, M. W., and Dowsett, M. A novel estrogen receptor variant mRNA lacking exons 4 to 6 in breast carcinoma. J. Steroid Biochem. Mol. Biol., 62: 419-430, 1997.
26. Cavaillès, V., Dauvois, S., Danielian, P. S., and Parker, M. G. Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natl. Acad. Sci. USA, 91: 10009-10013, 1994.
27. Oñate, S. A., Tsai, S. Y., Tsai, M-J., and O'Malley, B. W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science (Washington DC), 270: 1354-1357, 1995.